Article Versions Notes

Benčurová K, Friske J, Anderla M, Mayrhofer M, Wanek T, Nics L, Egger G, Helbich TH, Hacker M, Haug A, et al. CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [⁶⁸Ga]Ga-Pentixafor in CRC Imaging. Cancers. 2022; 14(22):5549. https://doi.org/10.3390/cancers14225549

Benčurová, Katarína, Joachim Friske, Maximilian Anderla, Manuela Mayrhofer, Thomas Wanek, Lukas Nics, Gerda Egger, Thomas H. Helbich, Marcus Hacker, Alexander Haug, and et al. 2022. "CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [⁶⁸Ga]Ga-Pentixafor in CRC Imaging" Cancers 14, no. 22: 5549. https://doi.org/10.3390/cancers14225549

Benčurová, K., Friske, J., Anderla, M., Mayrhofer, M., Wanek, T., Nics, L., Egger, G., Helbich, T. H., Hacker, M., Haug, A., Mitterhauser, M., & Balber, T. (2022). CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [⁶⁸Ga]Ga-Pentixafor in CRC Imaging. Cancers, 14(22), 5549. https://doi.org/10.3390/cancers14225549